BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26133293)

  • 21. The Identification, Review and Synthesis of Health State Utility Values from the Literature.
    Ara R; Brazier J; Peasgood T; Paisley S
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):43-55. PubMed ID: 29052156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of health state utility values and psychometric performance of generic preference-based instruments for children and adolescents with mental health problems.
    Thai TTH; Engel L; Perez JK; Tan EJ; Eades S; Sanci L; Mihalopoulos C
    Qual Life Res; 2023 Nov; 32(11):3005-3026. PubMed ID: 37237136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
    Hendrix N; Kim DD; Patel KS; Devine B
    Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Use of Mapping to Estimate Health State Utility Values.
    Ara R; Rowen D; Mukuria C
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):57-66. PubMed ID: 29052160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian Meta-Analysis of Health State Utility Values: A Tutorial with a Practical Application in Heart Failure.
    Santos JAR; Grant R; Di Tanna GL
    Pharmacoeconomics; 2024 Jul; 42(7):721-735. PubMed ID: 38767714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review and meta-analysis of utility values for lung cancer.
    Sturza J
    Med Decis Making; 2010; 30(6):685-93. PubMed ID: 20448248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating health state utility values for joint health conditions: a conceptual review and critique of the current evidence.
    Ara R; Wailoo AJ
    Med Decis Making; 2013 Feb; 33(2):139-53. PubMed ID: 22927696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals.
    Tosh JC; Longworth LJ; George E
    Value Health; 2011 Jan; 14(1):102-9. PubMed ID: 21211492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision analytical economic modelling within a Bayesian framework: application to prophylactic antibiotics use for caesarean section.
    Cooper NJ; Sutton AJ; Abrams KR
    Stat Methods Med Res; 2002 Dec; 11(6):491-512. PubMed ID: 12516986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy.
    Mott DJ; Najafzadeh M
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):33-9. PubMed ID: 26560704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in the measurement of health utilities in published cost-utility analyses.
    Brauer CA; Rosen AB; Greenberg D; Neumann PJ
    Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Health State Utility Values in Decision Models.
    Ara R; Brazier J; Zouraq IA
    Pharmacoeconomics; 2017 Dec; 35(Suppl 1):77-88. PubMed ID: 29052163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.